AI powered care Leverage Amalgam Rx’s AI powered SaMD platform and Medical Grade AI capabilities to position offerings to health systems and life sciences partners seeking decision support tools that integrate into clinical workflows and drive near real-time clinical decisions.

Global reach Target international health plans, providers, and biopharma partners given Amalgam’s footprint across four continents and existing collaborations, highlighting opportunities to expand beyond current markets and co develop global deployment strategies.

Enterprise partnerships Explore partnerships with pharmaceutical and device companies that require data driven decision support, leveraging Amalgam’s track record of collaborations (e.g., Novo Nordisk, Otsuka Precision Health) to propose joint go to market and integrated care solutions.

Financial signals Despite a modest revenue range, Amalgam has attracted sizable credit investments and a Series A, signaling investor confidence; sales motions can emphasize scalable deployment, recurring revenue through SaaM modules, and potential for larger multi product deals.

Expansion opportunities Capitalize on recent awards and recognition in AI space to craft co marketing and case study driven pitches; also pursue expansion with health plans and providers seeking AI guided care optimization and EHR integrated solutions in digital health adoption efforts.